OXFORD,
United Kingdom, Aug. 9, 2024
/PRNewswire/ -- Optellum, a global leader in AI-powered early
lung disease diagnosis & precision care, today announced it has
successfully achieved ISO 27001:2022 certification. This
prestigious milestone underscores Optellum's unwavering commitment
to best practices in information security and robust data
protection.
![Optellum is a medtech company that provides a ground-breaking AI platform to diagnose and treat early-stage lung cancer. Its mission is to ensure every lung-disease patient is diagnosed and treated at the earliest possible stage, when the probability of better health outcomes is highest. (PRNewsfoto/Optellum) Optellum is a medtech company that provides a ground-breaking AI platform to diagnose and treat early-stage lung cancer. Its mission is to ensure every lung-disease patient is diagnosed and treated at the earliest possible stage, when the probability of better health outcomes is highest. (PRNewsfoto/Optellum)](https://mma.prnewswire.com/media/1596737/Optellum_Logo.jpg)
ISO 27001 is a globally recognized standard that mandates
rigorous controls for establishing, maintaining, and certifying an
Information Security Management System (ISMS), and ensures the
highest standards of security in sourcing, handling, transferring,
and protecting sensitive information. Optellum's ISMS covers all
critical areas of a robust information security program including
design, development, manufacture, sales, and support of software
for clinical decision support for lung disease. The certification
process involved a systematic and documented approach to
safeguarding company and customer information, including
intellectual property, financial data, and entrusted third-party
information. The certification was awarded by BSI following a
rigorous independent audit.
Optellum's CEO, Dr Johnathan
Watkins, noting the milestone, said: "As a healthcare
technology company, protection of the assets and data of our
customers, partners, and employees is non-negotiable. I would like
to congratulate our exceptional staff, in particular Massoud and
our Information Security team. Their dedication and expertise have
made this achievement possible."
About Optellum
Optellum is a commercial-stage lung health company providing
artificial intelligence-based software & services that assist
healthcare professionals in early diagnosis and optimal treatment
for their patients. The company was founded so that every lung
disease patient is diagnosed and treated at the earliest possible
stage, when the probability of better health outcomes is highest.
The Oxford-based MedTech company's
flagship product, Virtual Nodule Clinic (VNC), has FDA 510(k)
clearance, CE marking, and CPT coding & CMS payment
classification under Medicare for the application of AI
decision-support software in lung cancer diagnosis. It has been
deployed in leading healthcare systems across the USA and Europe. Optellum has headquarters at the
Oxford Centre for Innovation in Oxford,
United Kingdom and a U.S. office at the Texas Medical Center
in Houston, Texas. For more
information, visit optellum.com or
follow on LinkedIn.
CONTACT: Optellum Communications | marketing@optellum.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/optellum-achieves-iso-270012022-certification-302218434.html
SOURCE Optellum